Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Atopaxar

Generic Name: Atopaxar

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₃₈FN_₃O_₅

CAS Number: 751475-53-3

Unique Ingredient Identifier: HTI275SD2D

Overview

Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.

Background

Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Randomized, Placebo-controlled Study to Evaluate Effects of E5555 on Renal Function Parameters and OCT2 Activity

Phase 1

Completed

Posted: 2010/11/16

Sponsor:Eisai Inc.

ID:NCT01241669

A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

Phase 2

Completed

Posted: 2008/02/20

Sponsor:Eisai Co., Ltd.

ID:NCT00619164

Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome

Phase 2

Completed

Posted: 2007/10/24

Sponsor:Eisai Inc.

ID:NCT00548587

Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease

Phase 2

Completed

Posted: 2006/04/07

Sponsor:Eisai Inc.

ID:NCT00312052

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy